BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
SandRidge Energy
SD
$503M
| $31.1M | ﹤0.01% |
2,402,549
+701,510
| +41% | +$9.71M |
|
|
ESPR
2702
DELISTED
Esperion Therapeutics
ESPR
| $31M | ﹤0.01% |
13,983,662
+11,144,842
| +393% | +$26.2M |
|
2703
iShares JPMorgan Broad USD Emerging Markets Bond ETF
BEMB
$42.2M
| $31M | ﹤0.01% |
600,000
| – | – |
|
2704
FRP Holdings
FRPH
$421M
| $30.9M | ﹤0.01% |
1,082,931
-17,793
| -2% | -$532K |
|
2705
iShares Large Cap Moderate Quarterly Laddered ETF
IVVM
$179M
| $30.8M | ﹤0.01% |
1,064,500
| – | – |
|
2706
Methode Electronics
MEI
$592M
| $30.8M | ﹤0.01% |
2,978,522
-2,834,899
| -49% | -$32.6M |
|
2707
Stantec
STN
$8.39B
| $30.7M | ﹤0.01% |
367,728
+40,372
| +12% | +$3.29M |
|
|
APLT
2708
DELISTED
Applied Therapeutics
APLT
| $30.7M | ﹤0.01% |
6,569,787
+5,580,510
| +564% | +$26.4M |
|
2709
iShares US Small Cap Equity Factor ETF
SMLF
$4.27B
| $30.6M | ﹤0.01% |
499,352
-4,791
| -1% | -$294K |
|
2710
Sierra Bancorp
BSRR
$525M
| $30.4M | ﹤0.01% |
1,360,330
+7,852
| +0.6% | +$161K |
|
2711
Sabesp
SBS
$18.7B
| $30.4M | ﹤0.01% |
11,663,812
-149,013
| -1% | -$436K |
|
2712
iShares International Dividend Growth ETF
IGRO
$1.32B
| $30.4M | ﹤0.01% |
450,742
+447,217
| +12,687% | +$29.9M |
|
|
NVRO
2713
DELISTED
NEVRO CORP.
NVRO
| $30.3M | ﹤0.01% |
3,600,357
+185,899
| +5% | +$1.98M |
|
|
HLVX
2714
DELISTED
HilleVax
HLVX
| $30.2M | ﹤0.01% |
2,090,604
+290,327
| +16% | +$3.99M |
|
2715
Atea Pharmaceuticals
AVIR
$420M
| $30.2M | ﹤0.01% |
9,120,563
-122,743
| -1% | -$458K |
|
2716
Vivid Seats
SEAT
$85.4M
| $30.2M | ﹤0.01% |
262,498
+7,386
| +3% | +$803K |
|
2717
Phathom Pharmaceuticals
PHAT
$692M
| $30.1M | ﹤0.01% |
2,926,373
+180,993
| +7% | +$1.86M |
|
2718
ArcelorMittal
MT
$55.3B
| $30.1M | ﹤0.01% |
1,314,465
-1,908,008
| -59% | -$48.8M |
|
2719
CALL
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
| $30.1M | ﹤0.01% |
+659,800
| New | +$30.7M |
|
2720
Telus
TU
$15.3B
| $30M | ﹤0.01% |
1,981,036
-91,394
| -4% | -$1.47M |
|
2721
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $30M | ﹤0.01% |
56,045
+20,310
| +57% | +$10.9M |
|
2722
Beyond Meat
BYND
$277M
| $29.9M | ﹤0.01% |
4,462,506
-93,896
| -2% | -$667K |
|
2723
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$322M
| $29.9M | ﹤0.01% |
1,202,549
-25,728
| -2% | -$637K |
|
2724
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $29.9M | ﹤0.01% |
723,244
+12,770
| +2% | +$529K |
|
2725
Ouster
OUST
$2.92B
| $29.8M | ﹤0.01% |
3,027,850
+2,364,730
| +357% | +$23.9M |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,440 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.